Nicola Long
14PUBLICATIONS
85CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Dec 23, 2025
Impact of Germline CHEK2 Pathogenic Variants on the Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome.Fei Yang, Nicola Long, Jonathan C Savage
|Nov 24, 2025
A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard Therapies.Stephen E Kurtz, Christopher A Eide, Andy Kaempf
|May 21, 2025
Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.Curtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena
|Feb 26, 2025
A CEBPB/IL-1β/TNF-α feedback loop drives drug resistance to venetoclax and MDM2 inhibitors in monocytic leukemia.Basil Allen, Daniel Bottomly, Thomas Köhnke
|Sep 12, 2023
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.Christopher A Eide, Stephen E Kurtz, Andy Kaempf
|Apr 23, 2023
NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia.Yonghong Li, Jose Solis-Ruiz, Fei Yang
Pageof 3
Frequent Collaborators
10 joint publications
Jeffrey W Tyner
8 joint publications
Brian J Druker
7 joint publications
Shannon McWeeney
6 joint publications
Christopher A Eide
6 joint publications
Stephen E Kurtz
4 joint publications
Anupriya Agarwal
4 joint publications
Richard Press
3 joint publications
Curtis A Lachowiez
3 joint publications
Bill H Chang
3 joint publications
Daniel A Pollyea
